Micrasim Capsules 10 thousand units, # 20

Micrasim caps.

10 thousand.

UNIT No. 20

Name ENG

MIKRAZYM

Clinical and pharmacological group

Enzyme preparation

ATX code

Multienzymes (lipase, protease etc.)

Dosage

10000U

Structure

Active ingredient: 10000 IU of Pancreatin in the form of enteric pellets (microgranules). Excipients: pellet shell (microgranules): Eudragit E-100 (methyl methacrylate, dimethylaminoethyl methacrylate and butyl methacrylate copolymer), triethyl citrate, emulsion capsicum, talcum shell, emulsion water, sodium lauryl sulfate, methyl parahydroxybenzoate (methylparaben, nipagin), propyl parahydroxybenzoate (propylparaben)

dyes: crimson dye (Ponceau 4R), quinoline yellow dye, patented blue dye, titanium dioxide.

Indications

Replacement therapy for exocrine pancreatic insufficiency: chronic pancreatitis, pancreatectomy, condition after irradiation, dyspepsia, cystic fibrosis

flatulence, diarrhea of ​​non-infectious genesis.

Impaired digestion of food (condition after resection of the stomach and small intestine): to improve the digestion of food in persons with normal function of the gastrointestinal tract in case of errors in nutrition (eating fatty foods, large amounts of food, irregular nutrition) and in case of impaired chewing function, sedentary lifestyle, prolonged immobilization.

Remheld's syndrome (gastrocardiac syndrome).

Storage conditions and periods

In a place protected from moisture and light, at a temperature not exceeding 25 degrees.

Expiration date: 2 years

INN / Active ingredient

pancreatin

Contraindications

Individual intolerance to pancreatin or individual components of the drug.

Acute pancreatitis, exacerbation of chronic pancreatitis.

Specifications

Category

Preparations for the gastrointestinal tract

,

Enzymes

Scope of the medicinal product

Gastrointestinal tract

Release form

Capsules

Manufacturer country

Russia

Package quantity, pcs

twenty

Scope of application

Gastroenterology

Minimum age from

From birth

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

OTCPharm

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Digestive Enzyme Remedy

Anatomical and therapeutic characteristics

A09AA02 Polyenzyme preparations (lipase + protease, etc.)

Dosage form

Capsules

Packaging

Box

The target audience

Children

Expiration date in days

730

Dosage (volume) of the substance in the preparation

pancreatin 168 mg

Package weight, g

45

Mode of application

:

The dose of the drug is selected individually, depending on the age, severity of symptoms and the composition of the diet. < br> Capsules are taken orally with a sufficient amount of non-alkaline liquid (water, fruit juices). If a single dose of the drug is more than 1 capsule, you should take half of the total number of capsules immediately before meals, and the other half during meals. If a single dose is 1 capsule, it should be taken with food. < br> If you have difficulty swallowing (for example, in children or the elderly), the capsule can be opened and taken directly in pellets, after mixing them with liquid or liquid food (pH < 5.0), which does not require chewing (applesauce, yogurt). < br> The permissible dose for children under the age of 1.5 years is 50,000 U / day, over 1.5 years - 100,000 U / day. < br> The duration of taking pancreatin can vary from several days (indigestion) to several months or years (long-term substitution therapy). < br> Substitution therapy for various types of exocrine pancreatic insufficiency < br> The dose is selected individually and depends on the severity of exocrine insufficiency, individual dietary habits and age of the patient. < br> Steatorrhea (more than 15 g of fat in feces per day) < br> In the presence of diarrhea, weight loss and lack of effect from diet therapy, 25,000 units of lipase are prescribed at each meal. < br> If necessary and with good tolerance, the dose is increased to 30,000-35,000 U of lipase per dose. < br> Further increase in the dose, in most cases, does not improve the results of treatment and requires a revision of the diagnosis,reduction of fat in the diet and / or additional prescription of drugs - proton pump inhibitors. < br> With mild steatorrhea, not accompanied by diarrhea and weight loss, appoint from 10,000 U to 25,000 U of lipase per intake. < br> Cystic fibrosis < The initial estimated dose for children under 4 years of age is 1000 U of lipase / kg of body weight at each feeding, for children over 4 years of age - 500 U of lipase / kg of body weight at each meal. < br> The dose should be adjusted individually, depending on the severity of the disease, the severity of steatorrhea and nutritional status. < br> The maintenance dose for most patients should not exceed 10,000 U of lipase / kg of body weight per day.With mild steatorrhea, not accompanied by diarrhea and a decrease in body weight, from 10,000 U to 25,000 U of lipase is prescribed per reception. < br> Cystic fibrosis < br> The initial calculated dose for children under 4 years old is 1000 U of lipase / kg of weight body at each feeding, for children over the age of 4 years - 500 U of lipase / kg of body weight at each meal. < br> The dose should be selected individually, depending on the severity of the disease, severity of steatorrhea and nutritional status. < br> Maintenance dose for most patients should not exceed 10,000 IU of lipase / kg of body weight per day.With mild steatorrhea, not accompanied by diarrhea and a decrease in body weight, from 10,000 U to 25,000 U of lipase is prescribed per reception. < br> Cystic fibrosis < br> The initial calculated dose for children under 4 years old is 1000 U of lipase / kg of weight body at each feeding, for children over the age of 4 years - 500 U of lipase / kg of body weight at each meal. < br> The dose should be selected individually, depending on the severity of the disease, the severity of steatorrhea and nutritional status. < br> Maintenance dose for most patients should not exceed 10,000 IU of lipase / kg of body weight per day.The initial calculated dose for children under 4 years of age is 1000 U of lipase / kg of body weight at each feeding, for children over 4 years of age - 500 U of lipase / kg of body weight at each meal. < br> The dose should be selected individually, depending on the severity of the disease, the severity of steatorrhea and nutritional status. < br> The maintenance dose for most patients should not exceed 10,000 U of lipase / kg of body weight per day.The initial calculated dose for children under 4 years of age is 1000 U of lipase / kg of body weight at each feeding, for children over 4 years of age - 500 U of lipase / kg of body weight at each meal. < br> The dose should be selected individually, depending on the severity of the disease, the severity of steatorrhea and nutritional status. < br> The maintenance dose for most patients should not exceed 10,000 U of lipase / kg of body weight per day.